{"transactions":[{"id":700523,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27708,"kind":"person","name":"Donofrio John Jr.","position":1,"cik":"0001679841","reported_name":"Donofrio John Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-30T20:31:10.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock, which vest on July 28, 2027."}],"balance_after":23762,"source":{"system":"sec-edgar","filing":"0001437749-26-025075","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774926025075/rdgdoc.xml","form_type":"4"}},{"id":1021990,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27708,"kind":"person","name":"Donofrio John Jr.","position":1,"cik":"0001679841","reported_name":"Donofrio John Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-10-07T20:06:59.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock, which vest on October 3, 2026."}],"balance_after":13762,"source":{"system":"sec-edgar","filing":"0001437749-25-030632","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000143774925030632/rdgdoc.xml","form_type":"4"}},{"id":1371040,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27708,"kind":"person","name":"Donofrio John Jr.","position":1,"cik":"0001679841","reported_name":"Donofrio John Jr.","relationship":{"director":true}}],"security":"Common Shares","published_at":"2024-11-09T01:34:59.000Z","date":"2024-11-06","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted shares, which vest on the earlier of November 6, 2025, or at the Issuer's next annual stockholder meeting."},{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which vest on the earlier of November 6, 2025, or at the Issuer's next annual stockholder meeting."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Grant of restricted shares, which vest on the earlier of November 6, 2025, or at the Issuer's next annual stockholder meeting."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Grant of restricted shares, which vest on the earlier of November 6, 2025, or at the Issuer's next annual stockholder meeting."}],"balance_after":3762,"source":{"system":"sec-edgar","filing":"0000912282-24-000762","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000091228224000762/form4.xml","form_type":"4"}},{"id":1807067,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27708,"kind":"person","name":"Donofrio John Jr.","position":1,"cik":"0001679841","reported_name":"Donofrio John Jr.","relationship":{"director":true}}],"security":"Common Shares","published_at":"2023-08-15T23:39:52.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which vest as follows:  1/3 on August 11, 2024, with the remaining restricted shares vesting in eight equal installments every three months beginning on November 11, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 1-for-20 reverse stock split effected by the Issuer on January 6, 2023."}],"balance_after":2262,"source":{"system":"sec-edgar","filing":"0000912282-23-000301","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000091228223000301/form4.xml","form_type":"4"}},{"id":2076609,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27708,"kind":"person","name":"Donofrio John Jr.","position":1,"cik":"0001679841","reported_name":"Donofrio John Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-23T22:40:12.000Z","date":"2022-12-21","kind":"disposition_to_issuer","acquired":false,"shares":187804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 21, 2022, the reporting person and the Issuer determined to rescind 187,804 vested shares of restricted common stock originally granted to the reporting person on April 16, 2021. The vesting of the remaining restricted shares remains unchanged with 1/12 vesting on the first day of each quarterly anniversary of the grant, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 21, 2022, the reporting person and the Issuer determined to rescind 187,804 vested shares of restricted common stock originally granted to the reporting person on April 16, 2021. The vesting of the remaining restricted shares remains unchanged with 1/12 vesting on the first day of each quarterly anniversary of the grant, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continued service with the Issuer."}],"balance_after":15267,"source":{"system":"sec-edgar","filing":"0001567619-22-022004","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000156761922022004/doc1.xml","form_type":"4"}},{"id":2746696,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27708,"kind":"person","name":"Donofrio John Jr.","position":1,"cik":"0001679841","reported_name":"Donofrio John Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-16T20:53:15.000Z","date":"2021-04-16","kind":"grant","acquired":true,"shares":187804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares. The restricted shares have the following accelerated vesting conditions: (1) The consummation of a Sale Event. (2) The closing price of the Company's stock price is equal or greater than forty dollars per share ($40) for two consecutive trading days. (3) The Grantee's service with the Company or a Related Entity is terminated by the Company without Cause (as defined below). The restricted shares vest as follows, and have no voting or dispositive rights until vested:  1/3 on April 16, 2022, and 1/12 on the first day of each quarter thereafter, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continuing employment with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted shares. The restricted shares have the following accelerated vesting conditions: (1) The consummation of a Sale Event. (2) The closing price of the Company's stock price is equal or greater than forty dollars per share ($40) for two consecutive trading days. (3) The Grantee's service with the Company or a Related Entity is terminated by the Company without Cause (as defined below). The restricted shares vest as follows, and have no voting or dispositive rights until vested:  1/3 on April 16, 2022, and 1/12 on the first day of each quarter thereafter, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continuing employment with the Issuer."}],"balance_after":203071,"source":{"system":"sec-edgar","filing":"0001567619-21-008230","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000156761921008230/doc1.xml","form_type":"4"}},{"id":3111496,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27708,"kind":"person","name":"Donofrio John Jr.","position":1,"cik":"0001679841","reported_name":"Donofrio John Jr.","relationship":{"director":true}}],"security":"Employee Stock Option Grant","published_at":"2020-06-12T21:45:39.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% vest on June 7, 2021, subject to the Grantee's continued service as a director on such dates."}],"balance_after":40038,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001654954-20-006584","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000165495420006584/section16.xml","form_type":"4"}},{"id":3782189,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27708,"kind":"person","name":"Donofrio John Jr.","position":1,"cik":"0001679841","reported_name":"Donofrio John Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-26T23:54:41.000Z","date":"2018-10-24","kind":"grant","acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares which vest on October 24, 2028, subject to earlier vesting in certain situations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Aggregate amount indicated reflects 20-for-1 reverse split and includes additional 2,663 post-split restricted shares previously issued."}],"balance_after":152663,"source":{"system":"sec-edgar","filing":"0001213900-18-014535","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390018014535/ownership.xml","form_type":"4"}},{"id":4167258,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27708,"kind":"person","name":"Donofrio John Jr.","position":1,"cik":"0001679841","reported_name":"Donofrio John Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-10T00:02:06.000Z","date":"2017-11-07","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted shares that vest on November 7, 2027, subject to earlier vesting in certain situations."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares that vest on November 7, 2027, subject to earlier vesting in certain situations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of these shares, 3,250 are restricted shares that vest on July 12, 2026, subject to earlier vesting in certain situations."}],"balance_after":53250,"source":{"system":"sec-edgar","filing":"0001213900-17-011710","document":"f4110717donofrio_aytubio.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000121390017011710/f4110717donofrio_aytubio.xml","form_type":"4"}},{"id":4379284,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27708,"kind":"person","name":"Donofrio John Jr.","position":1,"cik":"0001679841","reported_name":"Donofrio John Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option Grant","published_at":"2017-03-17T20:29:01.000Z","date":"2017-03-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These two transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vests on September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Grantee's continued service as a Director on such dates."}],"balance_after":15000,"derivative":{"exercise_price":0.82,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001638599-17-000301","document":"doc4_4278.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000301/doc4_4278.xml","form_type":"4"}},{"id":4379283,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":27708,"kind":"person","name":"Donofrio John Jr.","position":1,"cik":"0001679841","reported_name":"Donofrio John Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option Grant","published_at":"2017-03-17T20:29:01.000Z","date":"2017-03-16","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These two transactions involved an amendment of the exercise price of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vests on September 30, 2016, December 31, 2016, March 31, 2017 and June 30, 2017, subject to the Grantee's continued service as a Director on such dates."}],"balance_after":0,"derivative":{"exercise_price":3.23,"expiration_date":"2026-07-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001638599-17-000301","document":"doc4_4278.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000163859917000301/doc4_4278.xml","form_type":"4"}}]}